PROSPECTIVE STUDY ON DARATUMUMAB WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) DISEASES

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/bbce3cb74d983c5760878dd084cf2c9d.pdf
PROSPECTIVE STUDY ON DARATUMUMAB WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) DISEASES

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Kati
Kaartinen
Minna Seppälä minna.seppala@hus.fi Helsinki University Central Hospital Department of Nephrology Helsinki Finland -
Marja Kovala marja.kovala@hus.fi Helsinki University Central Hospital Department of Pathology Helsinki Finland -
Eero Honkanen eero.honkanen@fimnet.fi Helsinki University Central Hospital Department of Nephrology Helsinki Finland -
Anne Räisänen-Sokolowski anne.raisanen-sokolowski@hus.fi Helsinki University Central Hospital Department of Pathology Helsinki Finland -
Seppo Meri seppo.meri@helsinki.fi Helsinki University Central Hospital Department of Bacteriology and Immunology Helsinki Finland -
Juha Lievonen juha.lievonen@hus.fi Helsinki University Central Hospital Department of Hematology Helsinki Finland -
Sauli Vuoti sauli.vuoti@gmail.com University of Oulu Department of Internal and Biomedicine Oulu Finland -
Hannah Söderholm hannah.soderholm@hus.fi Helsinki University Central Hospital Department of Hematology Helsinki Finland -
Sini Luoma sini.luoma@hus.fi Helsinki University Central Hospital Department of Hematology Helsinki Finland -
Piia Matikainen piia.matikainen@omahame.fi Central Hospital of Kanta-Häme Department of Internal Medicine Hämeenlinna Finland -
Heli Uotinen heli.uotinen@omahame.fi Central Hospital of Kanta-Häme Department of Internal Medicine Hämeenlinna Finland -
Minna Lehto minna.lehto@omahame.fi Central Hospital of Kanta-Häme Department of Internal Medicine Hämeenlinna Finland -
Sorella Ilveskero sorella.ilveskero@hus.fi Helsinki University Central Hospital Department of Clinical Chemistry Helsinki Finland -
Samuli Rounioja samuli.rounioja@fimlab.fi Tampere University Hospital Department of Hematology Tampere Finland -
Kati Kaartinen kati.kaartinen@hus.fi Helsinki University Central Hospital Department of Nephrology Helsinki Finland *